Search results
AstraZeneca pulls its COVID-19 vaccine from the European market
WHIO-TV 7 Dayton· 2 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its ...
There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?
LA Times via Yahoo News· 2 hours agoIn years past, summer travel and gatherings have spurred surges in coronavirus infections. As...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 2 days agoIn a statement, the company the withdrawal was because “multiple variant COVID-19 vaccines have...
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about...
CBS News· 5 hours agoMore than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing...
AstraZeneca pulls COVID-19 vaccine from global markets
United Press International via Yahoo News· 2 days agoBritish-Swedish drug maker AstaZeneca is pulling its Vaxzevria COVID-19 vaccine from sale globally....
Study finds U.S. COVID-19 vaccine promotion campaign saved 50,000 lives
UPI· 4 days agoThe "We Can Do This" COVID-19 public education campaign launched by the White House in 2021 to...
AstraZeneca pulls its COVID-19 vaccine from the European market
San Francisco Chronicle· 2 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca pulls its COVID-19 vaccine from the European market
Atlanta Journal-Constitution· 2 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca pulls its COVID-19 vaccine from the European market
Associated Press· 2 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Reuters via Yahoo Finance· 13 hours agoNovavax on Friday removed doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 & ...